Accenture plc (ACN)

NYSE: ACN · USD

$244

+9.08 (+3.9%)· Recorded snapshot

İngilizce yedekTR

Çeviri yapılırken İngilizce kaynak gösteriliyor

Bu rapor henüz çevrilmedi. Çeviri kuyruğu yetiştiğinde birkaç dakika sonra sayfayı yenileyin.

StockMarketAgent Research · Analyzed 2026-10-18

Our latest published analysis: ACN rated Hold

Accenture plc's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$224 / share

Potential value

$275 / share

Upside to FV

-2.4%

from $244

Moat

7.8/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$140.6B
Revenue (ttm)	74.2B
Net income (ttm)	8.4B
EPS (ttm)	$13.6
Shares out	590.7M
P/E (trailing)	18.0x
P/E (forward)	12.4x
Dividend	$6.84 (2.81%)
Volume	4,361,803
Beta	1.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 74.2B
Net income (ttm): 8.4B
EPS (ttm): $13.6
P/E (trailing): 18.0x
P/E (forward): 12.4x
Market cap: $140.6B

Item	P1	P2	P3	P4	P5	Trend
Period	2022-08-31	2023-08-31	2024-08-31	2025-08-31	2026-08-31	Trend
Revenue	$61.59B	$64.11B	$64.90B	$69.67B	$74.18B	+4.8%
Gross profit	$19.70B	$20.73B	$21.16B	$22.24B	$23.78B	+4.8%
Operating income	$9.37B	$8.81B	$9.60B	$10.23B	$11.41B	+5.0%
Net income	$6.88B	$6.87B	$7.26B	$7.68B	$8.37B	+5.0%
EPS (diluted)	$10.71	$10.77	$11.44	$12.15	$13.56	+6.1%
EBITDA	$10.27B	$10.25B	$10.84B	$12.20B	$14.03B	+8.1%
R&D	$1.12B	$1.30B	$1.15B	$817.3M	$1.01B	-2.6%
SG&A	$4.23B	$4.28B	$4.28B	$4.35B	$4.82B	+3.3%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Sat
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Azalt
ADI	Analog Devices, Inc.	207.6B	50.9x	14.8x	11.0%	+16.4%	+76.9%	Sat
AAPL	Apple Inc.	5T	39.4x	10.8x	101.6%	+6.1%	+28.5%	Sat
ADBE	Adobe Inc.	97.1B	13.9x	3.7x	57.2%	+11.5%	-30.7%	Güçlü Al
AI	C3.ai, Inc.	2B	—	8.4x	-35.6%	+3.6%	-33.6%	Sat

Base and Bull scenarios

Bull20%

Price target

$275.15

+19.8% from spot

An accelerated transformation environment where enterprise generative AI spending scales rapidly across global corporations, driving premium earnings growth. Strong pricing power and high utilization allow operating margins to expand toward cycle highs, while capital returns accelerate via robust free cash flow conversion.

EPS growth of 9.5% in year 1, 9.0% in year 2, and 8.5% in year 3
Revenue growth accelerating to 6.0%-7.0% in local currency
Operating margin expanding annually toward peak levels driven by high-value reinvention engagements
Valuation multiple expanding toward premium enterprise technology peer levels on accelerated earnings growth

Base60%

Price target

$224.17

-2.4% from spot

The modal expected trajectory assumes revenue growth compounding at 4.5% to 5.1% annually through FY31, supported by steady managed services demand and moderate expansion in enterprise AI projects. Operating margins expand gradually from 15.38% to 16.0% in FY27, 16.2% in FY28, and reach 16.5% by FY31. Diluted share count decreases steadily via share repurchases.

Revenue growth of 4.5% in FY27, 5.1% in FY28, 5.0% in FY29, 4.8% in FY30, and 4.5% in FY31
Operating margin expanding from 16.0% in FY27 to 16.5% in FY31
Effective tax rate of 25.5%
Annual reinvestment rate of 8.0% of NOPAT
Terminal growth rate of 2.5% and terminal P/E multiple of 16.0x

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($224.17). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
8.4%	$242	$247	$253	$259	$266
8.9%	$228	$233	$237	$243	$248
9.4%	$217	$220	$224	$228	$233
9.9%	$206	$209	$213	$216	$220
10.4%	$197	$200	$202	$205	$209

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E12.4

P25 n/aP50 n/aP75 n/a

Trailing P/E16.9

P25 n/aP50 n/aP75 n/a

ROE26

P25 n/aP50 n/aP75 n/a

ROIC27.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ACN indicators

Market & fundamental data

Available fields

291

Groups with data

Currency

USD

Showing 291 of 291 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001467373
Company name	Accenture plc
Country	Ireland
Country code	US
CUSIP number	G1151C101
Earnings date	2026-12-17
Earnings time	bmo
Employees	814,000
Employees change	35,000
Employees growth	4.49%
Enterprise value	$144.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-08-31
First seen	2026-05-09
Fiscal year end	August
Founded	1989
In index	SP500
Industry	Information Technology Services
Is primary listing	Yes
Is SPAC	No
ISIN number	IE00B4BNMY34
Last 10-K release date	2026-10-16
Last earnings date	2026-10-01
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$144.3B
Market cap category	Large-Cap
Next earnings date	2026-12-17
Options	Yes
Price	$244.23
Price currency	USD
Sector	Technology
SIC code	7389
Stock price date	2026-10-28
Symbol	ACN
Tags	artificial-intelligence
Website	https://www.accenture.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	17.49x
Average P/E ratio (10Y)	25.92x
Average P/E ratio (3Y)	24.07x
Average P/E ratio (5Y)	25.96x
Earnings yield	5.55%
EV/Earnings	17.37x
EV/EBIT	11.93x
EV/EBITDA	10.83x
EV/FCF	12.51x
EV/Sales	1.96x
FCF / EV yield	7.99%
FCF yield	8.02%
Forward EV/Sales	1.88x
Forward P/E	16.61x
Forward P/S	1.87x
Graham number	127.18334
Graham upside	-48.12%
Industry forward P/E	15.27x
Industry P/E	21.4x
Lynch fair value	$97.82
Lynch upside	-60.1%
P/(FCF - SBC) ratio	15.21x
P/(OCF - SBC) ratio	14.11x
P/B ratio	4.44x
P/E ratio	18.01x
P/FCF ratio	12.46x
P/OCF ratio	11.71x
P/S ratio	1.95x
PEG ratio	2.31x
Price / tangible book value	78.65x
Price/EBITDA ratio	10.79x
Sector forward P/E	18.55x
Sector P/E	32.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.42%
EBITDA margin	18.09%
Effective tax rate	25.06%
FCF margin	15.66%
Gross margin	32.05%
Operating margin	16.42%
Pretax margin	15.33%
Profit margin	11.28%
Profit per employee	$10,279
Profitable quarters	100
Profitable years	29
Revenue per employee	$91,134
ROA	10.95%
ROA (5Y)	11.86%
ROCE	23.75%
ROE	26.02%
ROE (5Y)	27.86%
ROIC	27.86%
ROIC (5Y)	34.18%
SBC / revenue	2.83%
Tax / revenue	3.84%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	11.6%
EPS growth (Q)	46.45%
EPS growth (QoQ)	-13.41%
EPS growth 10Y	7.71%
EPS growth 3Y	7.98%
EPS growth 5Y	8.18%
EPS growth quarters	3
EPS growth years	9
FCF growth	6.86%
FCF growth (Q)	-25.25%
FCF growth (QoQ)	-20.97%
FCF growth 3Y	8.91%
FCF growth 5Y	6.72%
Gross profit growth	6.93%
Gross profit growth (Q)	6.66%
Gross profit growth 3Y	4.67%
Gross profit growth 5Y	7.76%
Net income growth	8.97%
Net income growth (Q)	40.83%
Net income growth (QoQ)	-14.87%
Net income growth 3Y	6.78%
Net income growth 5Y	7.21%
Net income growth quarters	3
Net income growth years	3
OCF growth	7.75%
OCF growth (Q)	-20.92%
OCF growth (QoQ)	-18.25%
OCF growth 10Y	10.23%
OCF growth 3Y	9.09%
OCF growth 5Y	6.62%
Operating income growth	12.22%
Operating income growth (Q)	24.34%
Operating income growth 3Y	7.25%
Operating income growth 5Y	9.83%
Revenue growth	6.47%
Revenue growth (Q)	6.15%
Revenue growth (QoQ)	-0.21%
Revenue growth 10Y	8.48%
Revenue growth 3Y	4.98%
Revenue growth 5Y	7.98%
Revenue growth quarters	9
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-742.7M
Depreciation and amortization	$1.2B
EBIT	$12.2B
EBITDA	$13.4B
EPS	$13.56
FCF per share	$19.67
Financing cash flow	$-5.3B
Free cash flow	$11.6B
Free cash flow minus SBC	$9.5B
Gross profit	$23.8B
Income taxes	$2.8B
Investing cash flow	$-5.6B
Net borrowing	$5B
Net cash flow	$1.4B
Net income	$8.4B
Operating cash flow minus SBC	$10.3B
Operating income	$12.2B
Revenue	$74.2B
Stock-based compensation	$2.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.13
Book value per share	$53.01
Debt / EBITDA	0.93
Debt / equity	0.4
Debt / FCF	1.15
Goodwill	$26.8B
Interest coverage	40.15
Long-term assets	$41.8B
Long-term liabilities	$18B
Net cash (debt)	$-559.2M
Net cash / market cap	-0.39%
Net debt / EBITDA	0.04
Net debt / equity	0.02
Net debt / FCF	0.05
Piotroski F-Score	6
Property, plant and equipment	$4.7B
Shareholders' equity	$33.3B
Tangible book value	$1.8B
Tangible book value per share	$3.09
Total assets	$73.6B
Total cash	$12.8B
Total debt	$13.4B
Total liabilities	$40.3B
WACC	9.58%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.07
Current assets	$31.8B
Current liabilities	$22.3B
Current ratio	1.43
Net working capital	$-2.4B
Quick ratio	1.31
Working capital	$9.5B
Working capital turnover	8.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.36%
Dividend growth	8.73%
Dividend growth (10Y)	11.07%
Dividend growth (3Y)	12.38%
Dividend growth (5Y)	12.83%
Dividend growth years	6
Dividend payment date	2026-11-13
Dividend payment years	22
Dividend payout frequency	Quarterly
Dividend per share	$6.84
Dividend yield	2.81%
Ex-dividend date	2026-10-13
FCF payout ratio	34.77%
Last dividend	$1.71
Payout ratio	50.43%
Shareholder yield	5.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	110.82%
10Y return CAGR	9.69%
10Y total return	152.07%
150-day SMA	$178.84
15Y price change	298.05%
15Y return CAGR	11.8%
15Y total return	432.86%
1D price change	3.86%
1M price change	38.22%
1M total return	39.32%
1W price change	1.79%
1W total return	1.79%
1Y price change	-2.93%
1Y return CAGR	0.44%
1Y total return	0.44%
20-day SMA	$223.10
200-day SMA	$191.68
20Y price change	649.18%
20Y return CAGR	12.69%
20Y total return	990.9%
3M price change	58%
3M total return	59.26%
3Y price change	-16.08%
3Y return CAGR	-3.42%
3Y total return	-9.92%
50-day SMA	$199.94
50-day SMA vs 200-day SMA	50over200
52-week high	$291.09
52-week high date	2026-01-14
52-week low	$118.15
52-week low date	2026-06-22
5Y price change	-31.25%
5Y return CAGR	-5.34%
5Y total return	-24.01%
6M price change	37.54%
6M total return	40.31%
All-time high	$417.37
All-time high date	2021-12-29
All-time low	$11.30
All-time low date	2002-10-07
Average true range (ATR)	$10.42
Average volume	7.9M
Beta (1Y)	0.36
Beta (2Y)	0.6
Beta (5Y)	1.1
Change from 52-week high	-16.1%
Change from 52-week low	106.71%
Change from all-time high	-41.68%
Change from all-time low	2,054.07%
Change from open	4.67%
Day's gap	-0.77%
Dollar volume	$1.1B
High price	$246.76
Low price	$233.34
Monthly RSI	49.95
Open price	$233.34
Position in 52-week range	81.15%
Premarket change	-0.57%
Premarket close	$235.16
Premarket price	$233.81
Premarket volume	33.2K
Previous close	$235.16
Price vs 150-day SMA	36.11%
Price vs 20-day SMA	9.11%
Price vs 200-day SMA	26.99%
Price vs 50-day SMA	21.74%
Relative volume	0.55
RSI	64.51
Sharpe ratio	0.18
Sharpe ratio (3Y)	-0.05
Sharpe ratio (5Y)	-0.11
Sortino ratio	0.37
Sortino ratio (3Y)	0.09
Sortino ratio (5Y)	0.02
Volume	4.4M
Weekly RSI	66.4
YTD price change	-9.28%
YTD total return	-6.12%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	589.7M
Float percentage	99.83%
Shares change (QoQ)	-1.67%
Shares change (YoY)	-2.36%
Shares held by insiders	0.04%
Shares held by institutions	83.97%
Shares outstanding	590.7M
Short % of float	3.34%
Short % of shares	3.34%
Short ratio	3.8 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	372

Deeper analysis on ACN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this ACN report

What is the latest published ACN stock rating?

Accenture plc is shown with Hold in the latest published report, analyzed 2026-10-18. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ACN analysis?

The full latest published report, analyzed 2026-10-18, lives at /stocks/ACN/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for ACN?

The latest published report analyzed 2026-10-18 gives ACN a fair value of USD 224 and a potential value of USD 275. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the ACN page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-18). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

HoldACN · Fair value $224-2.4%

Read full analysis →

Accenture plc (ACN)

Our latest published analysis: ACN rated Hold

Price

Financial snapshot

Fair-value bridge

Latest news · ACN

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All ACN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ACN

Frequently asked questions

Derecelendirme geçmişi

Category	Score	Reading
Valuation	4.5
Management	8.5
Balance Sheet	6.0
Profitability	7.5
Revenue Growth	6.0
Risk Assessment	6.5
Competitive Moat	7.8
Earnings Quality	9.0
Capital Efficiency	7.5